These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 26801567)
1. Generation and functional characterization of epithelial cells with stable expression of SLC26A9 Cl- channels. Salomon JJ; Spahn S; Wang X; Füllekrug J; Bertrand CA; Mall MA Am J Physiol Lung Cell Mol Physiol; 2016 Apr; 310(7):L593-602. PubMed ID: 26801567 [TBL] [Abstract][Full Text] [Related]
2. SLC26A9 is a constitutively active, CFTR-regulated anion conductance in human bronchial epithelia. Bertrand CA; Zhang R; Pilewski JM; Frizzell RA J Gen Physiol; 2009 Apr; 133(4):421-38. PubMed ID: 19289574 [TBL] [Abstract][Full Text] [Related]
3. Characterization of SLC26A9, facilitation of Cl(-) transport by bicarbonate. Loriol C; Dulong S; Avella M; Gabillat N; Boulukos K; Borgese F; Ehrenfeld J Cell Physiol Biochem; 2008; 22(1-4):15-30. PubMed ID: 18769029 [TBL] [Abstract][Full Text] [Related]
4. Separating the contributions of SLC26A9 and CFTR to anion secretion in primary human bronchial epithelia. Larsen MB; Choi JJ; Wang X; Myerburg MM; Frizzell RA; Bertrand CA Am J Physiol Lung Cell Mol Physiol; 2021 Dec; 321(6):L1147-L1160. PubMed ID: 34668421 [TBL] [Abstract][Full Text] [Related]
5. Resveratrol and ivacaftor are additive G551D CFTR-channel potentiators: therapeutic implications for cystic fibrosis sinus disease. Cho DY; Zhang S; Lazrak A; Grayson JW; Peña Garcia JA; Skinner DF; Lim DJ; Mackey C; Banks C; Matalon S; Woodworth BA Int Forum Allergy Rhinol; 2019 Jan; 9(1):100-105. PubMed ID: 30152192 [TBL] [Abstract][Full Text] [Related]
6. Role of the SLC26A9 Chloride Channel as Disease Modifier and Potential Therapeutic Target in Cystic Fibrosis. Balázs A; Mall MA Front Pharmacol; 2018; 9():1112. PubMed ID: 30327603 [TBL] [Abstract][Full Text] [Related]
7. Differential contribution of SLC26A9 to Cl(-) conductance in polarized and non-polarized epithelial cells. Ousingsawat J; Schreiber R; Kunzelmann K J Cell Physiol; 2012 Jun; 227(6):2323-9. PubMed ID: 21809345 [TBL] [Abstract][Full Text] [Related]
8. Slc26a9 is inhibited by the R-region of the cystic fibrosis transmembrane conductance regulator via the STAS domain. Chang MH; Plata C; Sindic A; Ranatunga WK; Chen AP; Zandi-Nejad K; Chan KW; Thompson J; Mount DB; Romero MF J Biol Chem; 2009 Oct; 284(41):28306-28318. PubMed ID: 19643730 [TBL] [Abstract][Full Text] [Related]
9. Expression of cystic fibrosis transmembrane conductance regulator in a model epithelium. Sheppard DN; Carson MR; Ostedgaard LS; Denning GM; Welsh MJ Am J Physiol; 1994 Apr; 266(4 Pt 1):L405-13. PubMed ID: 7513963 [TBL] [Abstract][Full Text] [Related]
10. Expression of SLC26A9 in Airways and Its Potential Role in Asthma. Ousingsawat J; Centeio R; Schreiber R; Kunzelmann K Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328418 [TBL] [Abstract][Full Text] [Related]
11. SLC26A9 stimulates CFTR expression and function in human bronchial cell lines. Avella M; Loriol C; Boulukos K; Borgese F; Ehrenfeld J J Cell Physiol; 2011 Jan; 226(1):212-23. PubMed ID: 20658517 [TBL] [Abstract][Full Text] [Related]
13. SLC26A9 as a Potential Modifier and Therapeutic Target in Cystic Fibrosis Lung Disease. Gorrieri G; Zara F; Scudieri P Biomolecules; 2022 Jan; 12(2):. PubMed ID: 35204703 [TBL] [Abstract][Full Text] [Related]
14. The SLC26A9 inhibitor S9-A13 provides no evidence for a role of SLC26A9 in airway chloride secretion but suggests a contribution to regulation of ASL pH and gastric proton secretion. Jo S; Centeio R; Park J; Ousingsawat J; Jeon DK; Talbi K; Schreiber R; Ryu K; Kahlenberg K; Somoza V; Delpiano L; Gray MA; Amaral MD; Railean V; Beekman JM; Rodenburg LW; Namkung W; Kunzelmann K FASEB J; 2022 Nov; 36(11):e22534. PubMed ID: 36183361 [TBL] [Abstract][Full Text] [Related]
15. Extent of rescue of F508del-CFTR function by VX-809 and VX-770 in human nasal epithelial cells correlates with SNP rs7512462 in SLC26A9 gene in F508del/F508del Cystic Fibrosis patients. Kmit A; Marson FAL; Pereira SV; Vinagre AM; Leite GS; Servidoni MF; Ribeiro JD; Ribeiro AF; Bertuzzo CS; Amaral MD Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1323-1331. PubMed ID: 30716472 [TBL] [Abstract][Full Text] [Related]
16. SLC26A9 is expressed in gastric surface epithelial cells, mediates Cl-/HCO3- exchange, and is inhibited by NH4+. Xu J; Henriksnäs J; Barone S; Witte D; Shull GE; Forte JG; Holm L; Soleimani M Am J Physiol Cell Physiol; 2005 Aug; 289(2):C493-505. PubMed ID: 15800055 [TBL] [Abstract][Full Text] [Related]
17. SLC26A9 in airways and intestine: secretion or absorption? Kunzelmann K; Centeio R; Ousingsawat J; Talbi K; Seidler U; Schreiber R Channels (Austin); 2023 Dec; 17(1):2186434. PubMed ID: 36866602 [TBL] [Abstract][Full Text] [Related]
18. SLC26A9 is a Cl(-) channel regulated by the WNK kinases. Dorwart MR; Shcheynikov N; Wang Y; Stippec S; Muallem S J Physiol; 2007 Oct; 584(Pt 1):333-45. PubMed ID: 17673510 [TBL] [Abstract][Full Text] [Related]
19. SLC26A9-mediated chloride secretion prevents mucus obstruction in airway inflammation. Anagnostopoulou P; Riederer B; Duerr J; Michel S; Binia A; Agrawal R; Liu X; Kalitzki K; Xiao F; Chen M; Schatterny J; Hartmann D; Thum T; Kabesch M; Soleimani M; Seidler U; Mall MA J Clin Invest; 2012 Oct; 122(10):3629-34. PubMed ID: 22945630 [TBL] [Abstract][Full Text] [Related]